Standard of care evaluation for Lenire treatment in patients with chronic subjective tinnitus

Standard of care evaluation for Lenire treatment in patients with chronic subjective tinnitus - Lenire PMCF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027993

Enrollment

150

Registered

2023-02-15

Start date

2022-01-18

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H93.1

Interventions

Group 1: Lenire tinnitus treatment following standard of care instructions

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: chronic subjective tinnitus

Exclusion criteria

Exclusion criteria: Contraindications according to manufacturer of Lenire treatment system Additional constraints that may affect participation in the study

Design outcomes

Primary

Measure	Time frame
Change in THI score after regular supervised treatment phase, compared to baseline-score (fitting appointment)	—

Secondary

Measure	Time frame
Change in THI score when the treatment continues beyond the regular supervised treatment phase, compared to baseline-score and the scores during the regular supervices treatment phase	—

Countries

Germany

Contacts

Public ContactPhilipp Becker

HörSys GmbH

lenire@hoersys.de+511 55476978

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026